{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-007359","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.900913+00:00","generated_at":"2026-06-18T05:47:03.277769+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Ginkgo Bioworks discloses ~$74M exposure to failed Silicon Valley Bank via Zymergen subsidiary","bullets":["Zymergen subsidiary holds ~$74M (6% of total cash) at Silicon Valley Bank.","SVB closed and FDIC appointed receiver as of March 10, 2023.","Company has no other material accounts or credit lines with SVB.","Cash reference point: $74M based on Dec 31, 2022 balance."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-007359","json":"https://secwatch.observer/filing/0000950170-23-007359.json","markdown":"https://secwatch.observer/filing/0000950170-23-007359.md","text":"https://secwatch.observer/filing/0000950170-23-007359.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000095017023007359/0000950170-23-007359-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000095017023007359/dna-20230301.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:47:03.277769+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}